- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT06891911
Mercearia para residentes do sudeste dos EUA para impedir a hipertensão (GoFreshSE)
GoFreshSE is a randomized control trial, testing the effects of a home-delivered, dietitian-assisted, DASH-patterned grocery intervention on blood pressure in adults with high blood pressure in Florida, Georgia, and Tennessee.
Visão geral do estudo
Status
Intervenção / Tratamento
Descrição detalhada
Hypertension (HTN) affects half of US adults and is one of the most important modifiable risk factors for cardiovascular disease (CVD) and death.
The DASH diet is a proven strategy for lowering blood pressure in adults. Our proposed clinical trial will evaluate the effectiveness of a scalable solution: home-delivered, low-sodium groceries aligned with the DASH dietary pattern and ordered with dietitian assistance via a virtual supermarket, in reducing blood pressure.
Participants will be assigned to one of two 1-month long interventions: (1) dietitian-assisted, DASH-patterned, home-delivered groceries ordered weekly through Amazon Fresh (or Whole Foods) over 4 weeks or (2) self-directed grocery shopping (monthly stipend and DASH diet brochure) (referent).
Tipo de estudo
Inscrição (Estimado)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
Massachusetts
-
Boston, Massachusetts, Estados Unidos, 02215
- Beth Israel Deaconess Medical Center
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- Resting systolic blood pressure of 120 to <160 mm Hg and diastolic blood pressure <110 mm Hg
- Resident of Florida, Georgia, and Tennessee
- Able to receive home-delivered groceries or pick them up at a convenient location and willing to eat only the groceries provided over a 4-week period
- Have access to refrigeration, cooking appliances, and Wi-Fi/cellular service
- Have access to mobile device or computer to be able to conduct grocery orders via video conference and send/receive text messages
- Willing and able to complete required measurement procedures
- Able to provide consent for the study
- Has access to a primary care team, urgent care center, or emergency room the study team can refer to for follow up care if warranted during the study
Exclusion Criteria:
A. Laboratory Exclusions:
- Serum potassium ≥5.4 mmol/L or <3.5 mmol/L
- Estimated glomerular filtration rate (eGFR) <30 mL/min per 1.73 m^2 by the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation
- Hemoglobin A1c ≥6.5%
B. Medication Exclusions:
Unstable doses (i.e. a change in the 6 months prior to screening or randomization or planning to start within study period) of the following:
- GLP-1 and dual GLP-1/GIP receptor agonists
- Anti-hypertension medications
- Sodium-glucose co-transporter 2 (SGLT2) inhibitors
- Glucose lowering medications
Use of any of the following medications:
- Potassium supplement, except if part of a multivitamin
- Warfarin (Coumadin)
- Chronic oral corticosteroid (intermittent use is okay)
- Weight loss medications (non-GLP-1 receptor agonists)
- Sulfonylurea or any insulin use
Any medication not compatible with participation as determined by the investigators
C. Physical Exclusions:
- Systolic blood pressure: <120 or ≥160 mm Hg or diastolic blood pressure ≥110 mm Hg
- Arm circumference >52 cm (or the upper limit of the validated BP device)
D. Medical History Exclusions:
- Self-reported weight loss or gain of 15 pounds during prior 2 months
- Active cardiovascular disease or any event in the prior 6 months, including coronary artery bypass grafting (CABG), percutaneous transluminal coronary angioplasty (PTCA), myocardial infarction (MI), cerebrovascular accident (CVA), or congestive heart failure (CHF) exacerbation requiring hospital admission
- Cancer diagnosis or treatment in the last 2 years (non-melanoma skin cancer or localized breast or prostate or bladder cancer not requiring systemic therapy is acceptable)
- Gastrointestinal surgery or history that affects nutrition absorption or requires a specific diet that will deter DASH diet adherence
- Pregnancy or lactation or planned pregnancy during the study period
- Any emergency department (ED) visit for asthma or chronic obstructive pulmonary disease (COPD) in the last 6 months
- Hypoglycemia hospitalization in the last 12 months
- Any other serious illness or condition not compatible with participation as determined by the investigators
E. Lifestyle and Other Exclusions:
- Significant food allergies, preferences, intolerances, or dietary requirements that would interfere with diet adherence
- Consumption of more than 14 alcoholic drinks per week or consumption of more than 6 drinks on one or more occasion per week
- Active substance use disorder that would interfere with participation
- Extreme food insecurity
- Participation in or planning to start weight loss program
- Current participation in another clinical trial that could interfere with the study protocol
- Anticipated change in residence outside of eligible states prior to the end of the study
- Families with more than 6 adults at dinner time (children count as half an adult)
F. Investigator discretion
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Dobro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Dietitian-Assisted DASH Groceries
Participants will order groceries sufficient to meet their caloric needs each week for 4 weeks with the assistance of a dietitian/nutrition interventionist. Groceries will be delivered to participants' homes or picked up at a convenient location. The dietitian/nutrition interventionist will provide brief educational content at the time of food delivery. Orders will be placed via phone or through virtual counseling sessions. |
The DASH ("Dietary Approaches to Stop Hypertension"), is a healthy dietary pattern that lowers blood pressure without reducing weight. The DASH diet emphasizes fruits, vegetables, and low-fat dairy products; includes whole grains, poultry, fish, and nuts; and is reduced in red meat, sweets, and sugar-containing beverages. Intervention Phase: This intervention is a weekly, 4-week DASH dietary intervention. A dietitian will assist participants in ordering groceries in a pattern consistent with the DASH diet to be delivered to their homes. The quantity of groceries will be based on participant Calorie needs and family size. |
|
Comparador Ativo: Self-directed shopping
Participants will receive a stipend and some basic information about healthy eating. The stipend is not restricted to foods. |
Intervention Phase: Participants will receive some basic information on healthy eating and a stipend during the 4-week intervention period. They are permitted to use the stipend however they choose and will not be asked about how they spent these funds. |
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Self-measured systolic blood pressure
Prazo: Measured before and after the 4-week intervention
|
This entails 4 measurements, 2 in the morning and 2 in the evening, over a 7 day period (at least 3 concurrent days is acceptable for analysis). |
Measured before and after the 4-week intervention
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Self-measured diastolic blood pressure
Prazo: Measured before and after the 4-week intervention
|
This entails 4 measurements, 2 in the morning and 2 in the evening, over a 7 day period (at least 3 concurrent days is acceptable for analysis). |
Measured before and after the 4-week intervention
|
|
Seated systolic and diastolic blood pressure (technician-measured)
Prazo: Measured before and after the 4-week intervention
|
Seated systolic and diastolic blood pressure measured by a technician in participants' homes, using the office blood pressure device. |
Measured before and after the 4-week intervention
|
|
Body Mass Index (BMI)
Prazo: Height is measured before the intervention. Weight is measured before and after the 4-week intervention.
|
At home measurement based on height and weight measured by a technician via a stadiometer and scale. |
Height is measured before the intervention. Weight is measured before and after the 4-week intervention.
|
|
24-hour dietary recall
Prazo: Measured before and after the 4-week intervention
|
Assessed via self-administered questionnaire using the Automated Self-Administered 24-Hour Dietary Recall (ASA24). |
Measured before and after the 4-week intervention
|
|
Spot urine sodium/potassium ratio
Prazo: Measured before and after the 4-week intervention
|
Measured in urine collected at the participants' homes. |
Measured before and after the 4-week intervention
|
|
Lipids
Prazo: Measured before and after the 4-week intervention
|
Measured in fasted serum specimens collected during phlebotomy. Includes total cholesterol, high density lipoprotein cholesterol, derived low density lipoprotein cholesterol, and triglycerides |
Measured before and after the 4-week intervention
|
|
Fasting glucose
Prazo: Measured before and after the 4-week intervention
|
Measured in blood as part of a basic metabolic panel |
Measured before and after the 4-week intervention
|
|
Serum potassium
Prazo: Measured before and after the 4-week intervention
|
Measured in blood as part of a basic metabolic panel |
Measured before and after the 4-week intervention
|
Outras medidas de resultado
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
General Health Status
Prazo: Measured before and after the 4-week intervention
|
Single General Health Status Question: "Would you say that in general your health is excellent, very good, good, fair, or poor?" |
Measured before and after the 4-week intervention
|
|
Financial strain
Prazo: Measured before and after the 4-week intervention
|
We will ask the following questions: How often does this describe you? I don't have money to pay my bills (including food, housing, medical care or heating). Never / Rarely / Sometimes / Often / Always |
Measured before and after the 4-week intervention
|
Colaboradores e Investigadores
Patrocinador
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- 2025P000102
- GRT67144 (Número de outro subsídio/financiamento: American Heart Association)
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Tipo de informação de suporte de compartilhamento de IPD
- PROTOCOLO DE ESTUDO
- SEIVA
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .